FDA warns of MI, death risk with regadenoson, adenosine

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FDA. FDA warns of rare but serious risk of heart attack and death with cardiac nuclear stress test drugs Lexiscan (regadenoson) and Adenoscan (adenosine). Internet Document : [4 pages], 20 Nov 2013. Available from: URL: http://www.fda.gov

FDA warns of MI, death risk with regadenoson, adenosine. Reactions Weekly 1481, 3 (2013). https://doi.org/10.1007/s40278-013-7556-y

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.